Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.

被引：1
|
作者：
Brieau, Bertrand
Dahan, Laetitia
De Rycke, Yann
Boussaha, Tarek
Vasseur, Philippe
Tougeron, David
Lecomte, Thierry
Coriat, Romain
Bachet, Jean Baptiste
Claudez, Pierre
Zaanan, Aziz
Soibinet, Pauline
Desrame, Jerome
Thirot-Bidault, Anne
Trouilloud, Isabelle
Mary, Florence
Locher, Christophe
Marthey, Lysiane
Cacheux, Wulfran
Lievre, Astrid
机构：
[1] Hop Cochin, F-75674 Paris, France
[2] Marseille Univ Hosp, Marseille, France
[3] Inst Curie, Dept Biostat, Paris, France
[4] Hop St Antoine, AP HP, F-75571 Paris, France
[5] CHU Poitiers, Poitiers, France
[6] Univ Poitiers Hosp, Dept Gastroenterol, Poitiers, France
[7] Ctr Hosp Trousseau, Tours, France
[8] Paris Descartes Univ, Cochin Teaching Hosp, AP HP, Paris, France
[9] Ctr Hosp Univ Pitie Salpetriere, Paris, France
[10] CHU St Etienne, St Etienne, France
[11] HEGP, Dept Gastroenterol, Paris, France
[12] CHU Reims, Reims, France
[13] Hop Prive Jean Mermoz, Lyon, France
[14] Hop Bicetre, Dept Hepatogastroenterol, Le Kremlin Bicetre, France
[15] Ambroise Pare, Paris, France
[16] Hop Avicenne, F-93009 Bobigny, France
[17] Meaux Hosp, Dept Hepatogastroenterol, Meaux, France
[18] Hop Bicetre, Le Kremlin Bicetre, France
[19] Inst Curie, Paris, France
[20] Inst Curie, Dept Med Oncol, St Cloud, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.4093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4093
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY FOR ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE STUDY
    Hirano, G.
    Takii, Y.
    Kamihira, T.
    Fujisawa, K.
    Ichiki, Y.
    Suzuki, T.
    Matsuo, T.
    Uraoka, S.
    Aoki, K. -I.
    Sakai, K. -I.
    Ogawa, R.
    Higuchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 121 - 121
  • [32] Second-line chemotherapy by FOLFIRI in patients with advanced small bowel adenocarcinoma A multicenter AGEO study
    Zaanan, A.
    Gauthier, M.
    Malka, D.
    Locher, C.
    Gornet, J.
    Thirot-Bidault, A.
    Tougeron, D.
    Taieb, J.
    Bonnetain, F.
    Aparicio, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Ricci, Angela Dalia
    Palloni, Andrea
    Messina, Carlo
    Spallanzani, Andrea
    Saccoccio, Gioconda
    Mollica, Veronica
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [34] Analysis of efficacy and prognostic factors for second-line chemotherapy in gemcitabine-refractory advanced biliary tract cancer
    Okano, N.
    Kawai, K.
    Kobayashi, T.
    Naruge, D.
    Nagashima, F.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
    Merz, Valeria
    Cavaliere, Alessandro
    Messina, Carlo
    Salati, Massimiliano
    Zecchetto, Camilla
    Casalino, Simona
    Milella, Michele
    Caffo, Orazio
    Melisi, Davide
    CANCERS, 2020, 12 (05)
  • [36] Pacritaxel as a second-line chemotherapy after failure of gemcitabine
    Egawa, Shinichi
    Motoi, Fuyuhiko
    Maeda, Shinpei
    Kitamura, Yo
    Ariake, Kyouhei
    Kawaguchi, Kei
    Tsukamoto, Hidekazu
    Yokoyama, Satoru
    Aoki, Takeshi
    Ottomo, Shigeru
    Sakata, Naoaki
    Okada, Takaho
    Fukuyama, Shoji
    Rikiyama, Toshiki
    Katayose, Yu
    Unno, Michiaki
    PANCREAS, 2008, 36 (02) : 222 - 222
  • [37] Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer
    Chikhareva, Y.
    Fedyanin, M.
    Bazin, I.
    Pokataev, I.
    Manukyan, M.
    Kantieva, D.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S131 - S131
  • [38] Phase II study of sunitinib as second-line treatment in advanced biliary tract carcinoma: Multicenter, multinational study.
    Yi, J.
    Thongprasert, S.
    Doval, D.
    Lee, J.
    Cho, M. N.
    Park, S. H.
    Park, J. O.
    Park, Y. S.
    Kang, W. K.
    Lim, H. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Second-Line Chemotherapy With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI Regimen) in Patients With Advanced Small Bowel Adenocarcinoma After Failure of First-Line Platinum-Based Chemotherapy A Multicenter AGEO Study
    Zaanan, Aziz
    Gauthier, Melanie
    Malka, David
    Locher, Christophe
    Gornet, Jean-Marc
    Thirot-Bidault, Anne
    Tougeron, David
    Taieb, Julien
    Bonnetain, Franck
    Aparicio, Thomas
    CANCER, 2011, 117 (07) : 1422 - 1428
  • [40] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345